|
Market Closed -
Swiss Exchange
12:30:30 2026-10-30 EDT
|
5-day change | 1st Jan Change | ||
| 42.00 CHF | -3.23% |
|
-4.44% | +60.92% |
| 10-26 | Polypeptide Group Ag Announces Board and Committee Changes | CI |
| 10-16 | Samsung Biologics' PolyPeptide Offer Tops 87% Participation Rate | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1.68B | |||||
| 1,263B | |||||
| 658B | |||||
| 521B | |||||
| 391B | |||||
| 369B |
- Stock Market
- Stocks
- PPGN Stock
- Charts PolyPeptide Group AG
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
